Diagnostic chain operator Thyrocare Technologies (NSE:THYROCARE, BOM:539871) has agreed to invest an additional $25,000 in its joint venture company Thyrocare Laboratories (Tanzania), according to a Monday filing to the Indian stock exchanges,
Following the investment and on the allotment of shares by the JV company, Thyrocare Laboratories (Tanzania) will become a subsidiary of the company.
The joint venture company provides diagnostic and healthcare services directly to customers in Tanzania.
Price (INR): ₹659.50, Change: ₹-3.6, Percent Change: -0.54%
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。